Adiponectin Action from Head to Toe

Overview

Journal Endocrine

Specialty Endocrinology

Date 2010 Oct 22

PMID 20963555

Citations 130

Authors

Karine Brochu-Gaudreau

Charlotte Rehfeldt

Richard Blouin

V Bordignon

Bruce D Murphy

Marie-France Palin

Affiliations

Soon will be listed here.

Abstract

Adiponectin, the most abundant protein secreted by white adipose tissue, is known for its involvement in obesity-related disorders such as insulin resistance, type 2 diabetes mellitus and atherosclerosis. Moreover, modulation of the circulating adiponectin concentration is observed in pathologies that are more or less obesity-related, such as cancer and rheumatoid arthritis. The wide distribution of adiponectin receptors in various organs and tissues suggests that adiponectin has pleiotropic effects on numerous physiological processes. Besides its well-known insulin-sensitizing, anti-inflammatory and antiatherosclerotic properties, accumulating evidence suggests that adiponectin may also have anticancer properties and be cardioprotective. A beneficial effect of adiponectin on female reproductive function was also suggested. Since adiponectin has numerous beneficial biological functions, its use as a therapeutic agent has been suggested. However, the use of adiponectin or its receptors as therapeutic targets is complicated by the presence of different adiponectin oligomeric isoforms and production sites, by multiple receptors with differing affinities for adiponectin isoforms, and by cell-type-specific effects in different tissues. In this review, we discuss the known and potential roles of adiponectin in various tissues and pathologies. The therapeutic promise of administration of adiponectin and the use of its circulating levels as a diagnostic biomarker are further discussed based on the latest experimental studies.

Citing Articles

Research progress on the correlation between obesity and the occurrence and development of kidney cancer: a narrative review.

Kang L, Chen X, Qi P, Ma Z, Han D, Zhang X Transl Cancer Res. 2024; 13(10):5678-5690.

PMID: 39525017 PMC: 11543094. DOI: 10.21037/tcr-24-744.

Aging alters the effect of adiponectin receptor signaling on bone marrow-derived mesenchymal stem cells.

Liu H, Zhao Q, Liu S, Li B, Zheng Z, Liu Y Aging Cell. 2024; 24(2):e14390.

PMID: 39462849 PMC: 11822658. DOI: 10.1111/acel.14390.

The Role of Adipose Tissue and Nutrition in the Regulation of Adiponectin.

Baldelli S, Aiello G, Mansilla Di Martino E, Campaci D, Muthanna F, Lombardo M Nutrients. 2024; 16(15).

PMID: 39125318 PMC: 11313710. DOI: 10.3390/nu16152436.

Association of DNA Methylation with Infant Birth Weight in Women with Gestational Diabetes.

Saucedo R, Ferreira-Hermosillo A, Robledo-Clemente M, Diaz-Velazquez M, Valencia-Ortega J Metabolites. 2024; 14(7).

PMID: 39057684 PMC: 11278577. DOI: 10.3390/metabo14070361.

Adiponectin blood levels and autism spectrum disorders: a systematic review.

Ali M, Kamran M, Talha M, Shad M BMC Psychiatry. 2024; 24(1):88.

PMID: 38297246 PMC: 10832114. DOI: 10.1186/s12888-024-05529-1.

References

Kotronen A, Yki-Jarvinen H, Aminoff A, Bergholm R, Pietilainen K, Westerbacka J . Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Eur J Endocrinol. 2009; 160(4):593-602. DOI: 10.1530/EJE-08-0900. View

Takahashi T, Saegusa S, Sumino H, Nakahashi T, Iwai K, Morimoto S . Adiponectin replacement therapy attenuates myocardial damage in leptin-deficient mice with viral myocarditis. J Int Med Res. 2005; 33(2):207-14. DOI: 10.1177/147323000503300208. View

Combs T, Berg A, Rajala M, Klebanov S, Iyengar P, Jimenez-Chillaron J . Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 2003; 52(2):268-76. DOI: 10.2337/diabetes.52.2.268. View

Pischon T, Pai J, Manson J, Hu F, Rexrode K, Hunter D . Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women. Obesity (Silver Spring). 2007; 15(8):2051-60. DOI: 10.1038/oby.2007.244. View

Punyadeera C, Zorenc A, Koopman R, McAinch A, Smit E, Manders R . The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle. Eur J Endocrinol. 2005; 152(3):427-36. DOI: 10.1530/eje.1.01872. View

Sir-Petermann T, Maliqueo M, Codner E, Echiburu B, Crisosto N, Perez V . Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007; 92(12):4637-42. DOI: 10.1210/jc.2007-1036. View

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1):79-83. DOI: 10.1006/bbrc.1999.0255. View

Catalano P, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S . Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia. 2006; 49(7):1677-85. DOI: 10.1007/s00125-006-0264-x. View

Petrone A, Zavarella S, Caiazzo A, Leto G, Spoletini M, Potenziani S . The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity. Obesity (Silver Spring). 2006; 14(9):1498-504. DOI: 10.1038/oby.2006.172. View

10.

Shibata R, Sato K, Pimentel D, Takemura Y, Kihara S, Ohashi K . Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 2005; 11(10):1096-103. PMC: 2828682. DOI: 10.1038/nm1295. View

11.

. Nutrition and reproduction in women. Hum Reprod Update. 2006; 12(3):193-207. DOI: 10.1093/humupd/dmk003. View

12.

Xita N, Georgiou I, Chatzikyriakidou A, Vounatsou M, Papassotiriou G, Papassotiriou I . Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem. 2004; 51(2):416-23. DOI: 10.1373/clinchem.2004.043109. View

13.

Psilopanagioti A, Papadaki H, Kranioti E, Alexandrides T, Varakis J . Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology. 2008; 89(1):38-47. DOI: 10.1159/000151396. View

14.

Barber T, Hazell M, Christodoulides C, Golding S, Alvey C, Burling K . Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition. J Clin Endocrinol Metab. 2008; 93(7):2859-65. DOI: 10.1210/jc.2007-2759. View

15.

Yildirim B, Sabir N, Kaleli B . Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003; 79(6):1358-64. DOI: 10.1016/s0015-0282(03)00265-6. View

16.

Rodriguez-Pacheco F, Martinez-Fuentes A, Tovar S, Pinilla L, Tena-Sempere M, Dieguez C . Regulation of pituitary cell function by adiponectin. Endocrinology. 2006; 148(1):401-10. DOI: 10.1210/en.2006-1019. View

17.

Hoefle G, Muendlein A, Saely C, Risch L, Rein P, Koch L . The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men. Thromb Haemost. 2007; 97(3):451-7. View

18.

Ajuwon K, Spurlock M . Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol. 2004; 288(5):R1220-5. DOI: 10.1152/ajpregu.00397.2004. View

19.

Fiaschi T, Cirelli D, Comito G, Gelmini S, Ramponi G, Serio M . Globular adiponectin induces differentiation and fusion of skeletal muscle cells. Cell Res. 2009; 19(5):584-97. DOI: 10.1038/cr.2009.39. View

20.

Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K . PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001; 50(9):2094-9. DOI: 10.2337/diabetes.50.9.2094. View